Ron Cohen and Amitabh Chandra will be speaking at the Evolution Summit this February!
Marcus Evans is proud to announce that Ron Cohen, M.D., President, CEO and founder of Acorda Therapeutics, Inc., and Amitabh Chandra, Malcolm Wiener Professor of Social Policy and Director of Health Policy Research at the Harvard Kennedy School of Government will be speakers at the Evolution Summit, taking place on 24th-26th February at The Ritz Carlton in Rancho Mirage, California.
Dr. Ron Cohen is President, CEO and founder of Acorda Therapeutics, Inc., a public biotechnology company developing therapies for disorders of the nervous system, including multiple sclerosis, Parkinson’s disease and migraine. He serves on the Board of Directors of VBL Therapeutics. He also is immediate past Chair of the Board of the Biotechnology Innovation Organization (BIO), and previously served as Chair of the New York Biotechnology Association (NYBA).
Acorda Therapeutics has been recognized as one of the Best Companies to Work for in New York State seven years in a row (2011-2017), among the Fortune 100 Best Medium-Size Workplaces the U.S. (2017), and among the Fortune 100 Best Workplaces for Women (2016-2017), Millennials (2017) and Baby Boomers (2017).
Dr. Cohen is a recipient of the NY CEO Lifetime Achievement Award and the Ernst & Young Entrepreneur of the Year Award for the New York Metropolitan Region. He was named Neuroinvestment’s CEO of the Year, has been recognized by the New York Biotechnology Association as the NYBA “The Cures Start Here” Business Leader of the Year, and by PharmaVOICE Magazine as one of the 100 Most Inspirational People in the Biopharmaceutical Industry. He is Board certified in Internal Medicine.
Amitabh Chandra is the McCance Family Professor of Business Administration at Harvard Business School and the Malcolm Wiener Professor of Social Policy at the Harvard Kennedy School of Government.
Professor Chandra is a member of the Congressional Budget Office's (CBO) Panel of Health Advisors, and is a Research Associate at the National Bureau of Economic Research (NBER). His research focuses on innovation in healthcare, medical malpractice, and racial disparities in healthcare. His research has been supported by the National Institute of Aging, the National Institute of Child Health and Development, the Robert Wood Johnson Foundation, and has been published in the American Economic Review, the Journal of Political Economy, the New England Journal of Medicine, the Journal of the American Medical Association, and Health Affairs.
Professor Chandra is an elected member of the National Academy of Medicine, the first-prize recipient of the Upjohn Institute's Dissertation Award, the Kenneth Arrow Award for best paper in health economics, the Eugene Garfield Award for the impact of medical research, and the American Society of Health Economists Medal for the best health economist under age 40.
At the Evolution Summit, Dr. Cohen will moderate a panel discussion on ‘Reaping Success in Your Sponsor/CRO Partnership: Accountability, Transparency and Relationship Management’. The panel of experts will detail their outsourcing model and provide insights into:
- Maximizing the mutual benefits to be derived from the partnership
- Establishing accountability throughout the relationship
- Efficiently handling risk sharing throughout the partnership
- Maintaining clear channels of communication and transparency to ensure efficiency
- Effectively handling CRO turnover
- Evaluating the current state of US drug prices and the accompanying criticisms
- How can the high cost of drugs be managed during the clinical development process? Understanding the link
- Outlining the strategies to be implemented to aid in lowering drug prices